Bromelain Market Size, Share, Demand, Key players Analysis and Forecast 2024-2032

Comments · 23 Views

Bromelain is a protease or protein-digesting enzyme derived from the fruit and stem of the pineapple plant. It is an inhibitor of blood platelet aggregation, which minimizes the risk of arterial thrombosis and embolism and consequently finds extensive utilization in the treatment of cardio

The latest report by IMARC Group, titled “Bromelain Market Report by Source (Stem, Fruit), Application (Healthcare, Food and Beverages, Cosmetics, and Others), and Region 2024-2032“, The global bromelain market size is expected to exhibit a growth rate (CAGR) of 6.3% during 2024-2032.

Bromelain is a natural enzyme found in pineapple that has various health benefits. It helps prevent blood clotting, reduces the risk of cardiovascular diseases, interferes with tumor cells, and aids in reducing inflammation and pain. It also promotes wound healing and is used as an alternative to NSAIDs. Additionally, bromelain can alleviate swelling, congestion, joint stiffness, and treat inflammatory bowel disorders. Due to its many advantages, bromelain is widely used in healthcare, cosmetics, and the food and beverage industries worldwide.

Bromelain Market Trends and Drivers:

The market is experiencing significant growth, largely due to the rapid expansion of the healthcare sector. The increasing prevalence of diseases such as cancer, asthma, rheumatoid arthritis, and cardiovascular conditions is also fueling market growth. The pharmaceutical industry's growing demand for bromelain, driven by its anti-inflammatory and pain-relieving properties, is another key factor contributing to supplement, bromelain is commonly used to reduce post-operative as alleviate symptoms of osteoarthritis, diarrhea, and diabetes. Additionally, its ability to enhance drug absorption has made it a popular choice among patients. Furthermore, athletes are increasingly turning to bromelain to manage inflammation caused by injuries, while its use in treating chronic inflammatory, malignant, and autoimmune conditions is also on the rise. The growing need for bromelain as an oral enzyme therapy for oncology patients, which can be absorbed by the intestines without losing its potency, is another driving force behind the market's growth. The growing need for tenderized meat in the food and beverage industry, particularly seafood sector, is driving up demand for the enzyme bromelain, thereby market expansion. The bromelain market is experiencing varied growth rates globally, with North America emerging as a major market due to increasing demand in the healthcare sector, rising consumer spending power, and growing awareness of the benefits of bromelain. However, the industry is poised to face intense competition in the coming years as key players adopt aggressive strategies to maintain their market presence. For example, Advanced Enzymes Technologies Limited strengthened its research and development capabilities and expanded its product portfolio by acquiring a 100% stake in Germany-based evoxx technologies GmbH in 2017.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bromelain-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Source:

  • Stem
  • Fruit

Breakup by Application:

  • Healthcare
  • Food and Beverages
  • Cosmetics
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Advanced Enzyme Technologies Limited
  • Bio-gen Extracts Private Limited.
  • Changsha Natureway Co. Ltd.
  • Creative Enzymes
  • Enzybel International (Floridienne S.A.)
  • Enzyme Development Corporation
  • Enzyme Technologies (PTY) Ltd.
  • Guangxi Nanning Javely Biological Products Co. Ltd.
  • Hong Mao Biochemicals Co. Ltd.
  • Mitushi Biopharma
  • Xena Bio Herbals Pvt. Ltd.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

 

 

Comments